Acta Med. 2002, 45: 19-27
https://doi.org/10.14712/18059694.2019.52
The Influence of Oxime Selection on the Efficacy of Antidotal Treatment of Soman-Poisoned Rats
References
1. J, Patočka J, Herink J, Fusek J, Hrdina J. Effect of benactyzine, atropine and chlorpromazine on blood-brain barrier permeability in rats. Activ Nerv Sup 1978; 20:56–62.
2. J. Present view on toxidynamics of soman poisoning. Acta Med (Hradec Králové) 1996; 39:101–5.
3. EC, Foster RE, Beers ET, Rickett DL, Filbert MG. Neurophysiological concomitants of soman-induced respiratory depression in awake, behaving guinea pigs. Toxicol Appl Pharmacol 1990; 102:233–8.
<https://doi.org/10.1016/0041-008X(90)90023-N>
4. JG. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat. Biochem Pharmacol 1982; 31:1283–7.
<https://doi.org/10.1016/0006-2952(82)90017-X>
5. JG. Central activity of acetylcholinesterase oxime reactivators. Toxicol Appl Pharmacol 1992; 112:104–9.
<https://doi.org/10.1016/0041-008X(92)90285-Z>
6. RM. Review of oximes available for the treatment of nerve agent poisoning. J Appl Toxicol 1994; 14:317–31.
<https://doi.org/10.1002/jat.2550140502>
7. EHJr, Nikaido AM, Gupta SK, Heatherly DG, Nishita JK. Comparison of central nervous system and peripheral pharmacodynamics to atropine pharmacokinetics. J Pharmacol Exp Ther 1990; 255:1133–41.
8. JH, Harris JW. Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate. Biochem Pharmacol 1965; 14:641–9.
<https://doi.org/10.1016/0006-2952(65)90082-1>
9. T, Raveh L, Cohen G et al. Distribution of 3H–soman in mice. Arch Toxicol 1985; 58:45–9.
<https://doi.org/10.1007/BF00292616>
10. J. Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 1995; 101:167–74.
<https://doi.org/10.1016/0300-483X(95)03091-S>
11. J, Bajgar J. Changes of acetylcholinesterase activity in various parts of brain following non-treated and treated soman poisoning in rats. Mol Chem Neuropathol 1998; 33:175–84.
<https://doi.org/10.1007/BF02815180>
12. J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 1999; 132:111–8.
<https://doi.org/10.1016/S0300-483X(98)00146-2>
13. , J, Fusek J. The influence of anticholinergic drug selection on the efficacy of antidotal treatment of soman-poisoned rats. Toxicology 2000; 154:67–73.
<https://doi.org/10.1016/S0300-483X(00)00322-X>
14. A. REM sleep pathway and anticholinesterase intoxication: a mechanism for nerve agent-induced central respiration failure. Med Hypotheses 1993; 41:141–9.
<https://doi.org/10.1016/0306-9877(93)90061-T>
15. G, Dorandeu F, Filliat P, Carpentier P, Baille V, Blanchet G. Medical management of organophosphate-induced seizures. J Physiol (Paris) 1998; 92:369–73.
<https://doi.org/10.1016/S0928-4257(99)80007-2>
16. PM, Shih T-M. Examination of the role of central cholinergic mechanisms in the therapeutic effects of HI-6 in organophosphate poisoning. J Neurochem 1983; 40:1321–7.
<https://doi.org/10.1111/j.1471-4159.1983.tb13573.x>
17. TC. Organophosphate poisoning. Pharmacol Ther 1993; 58:51–66.
<https://doi.org/10.1016/0163-7258(93)90066-M>
18. JR, Shih T-M. Neuropharmacological mechanisms of nerve agent – induced seizure and neuropathology. Neurosci Biobehav Rev 1997; 21:559–79.
<https://doi.org/10.1016/S0149-7634(96)00050-4>
19. S, Takase M, Kunagoi F. Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int Rev Arm Force Med Ser 1996; 69:97–102.
20. CG, Dua AK. Pharmacology of HI-6, an H series oximes. Can J Physiol Pharmacol 1989; 67:1183–9.
<https://doi.org/10.1139/y89-188>
21. AM, Farsakh NA, Al-Ali MK. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart 1997; 77:461–8.
<https://doi.org/10.1136/hrt.77.5.461>
<PubMed>
22. Sachs, L.: Angewandte Statistik, 2nd ed. Springer, Berlin, 1992:p. 207.
23. T-M, Whalley ChE, Valdes JJ. A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicol Lett 1991; 55:131–47.
24. T-M. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Arch Toxicol 1993; 67:637–46.
<https://doi.org/10.1007/BF01974071>
25. Taylor P. Anticholinesterase agents. In: The Pharmacological Basis of Therapeutics, 9th ed. Eds.: Hardman JG, Limbird LE. McGraw Hill, New York, USA, 1996: pp. 161–76.
26. L, Clement JG. Histomorphogenesis of soman-induced encephalocardiomyopathy in Sprangue-Dawley rats. Toxicol Pathol 1995; 23:393–7.
<https://doi.org/10.1177/019262339502300316>
27. HPM, Busker RW, Melchers BPC, Brijunzeel PLB. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996; 70:779–86.
<https://doi.org/10.1007/s002040050340>
